http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 20 Aug 2026 07:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html <p>BRISBANE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein degradation medicines for patients with cancer and inflammatory diseases, today announced that Wes Burwell has joined Nurix as its Chief Human Resources Officer (CHRO). Mr. Burwell will serve as a member of the company’s Executive Management Team and will lead Nurix&apos;s human resources organization as the company advances its late-stage clinical pipeline and prepares for commercialization while maintaining its leadership position in targeted protein degradation drug discovery research.</p> <p>&quot;Nurix is entering a new chapter as we evolve http://www.streetinsider.com/Press+Releases/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html Thu, 20 Aug 2026 07:00:00 -0400 A.15133668 A.26631359 A.50113906 NRIX O.13716952 O.19990958 O.19997584 O.48084002 http://www.streetinsider.com/Press+Releases/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html <p>BRISBANE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein degradation medicines for patients with cancer and inflammatory diseases, today announced that Wes Burwell has joined Nurix as its Chief Human Resources Officer (CHRO). Mr. Burwell will serve as a member of the company’s Executive Management Team and will lead Nurix&apos;s human resources organization as the company advances its late-stage clinical pipeline and prepares for commercialization while maintaining its leadership position in targeted protein degradation drug discovery research.</p> <p>&quot;Nurix is entering a new chapter as we evolve http://www.streetinsider.com/Press+Releases/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html Thu, 20 Aug 2026 07:00:00 -0400 A.15133668 A.26631359 A.50113906 NRIX O.13716952 O.19990958 O.19997584 O.48084002 http://www.streetinsider.com/Press+Releases/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html <p>BRISBANE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein degradation medicines for patients with cancer and inflammatory diseases, today announced that Wes Burwell has joined Nurix as its Chief Human Resources Officer (CHRO). Mr. Burwell will serve as a member of the company’s Executive Management Team and will lead Nurix&apos;s human resources organization as the company advances its late-stage clinical pipeline and prepares for commercialization while maintaining its leadership position in targeted protein degradation drug discovery research.</p> <p>&quot;Nurix is entering a new chapter as we evolve http://www.streetinsider.com/Press+Releases/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html Thu, 20 Aug 2026 07:00:00 -0400 A.15133668 A.26631359 A.50113906 NRIX O.13716952 O.19990958 O.19997584 O.48084002 http://www.streetinsider.com/Press+Releases/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html <p>BRISBANE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein degradation medicines for patients with cancer and inflammatory diseases, today announced that Wes Burwell has joined Nurix as its Chief Human Resources Officer (CHRO). Mr. Burwell will serve as a member of the company’s Executive Management Team and will lead Nurix&apos;s human resources organization as the company advances its late-stage clinical pipeline and prepares for commercialization while maintaining its leadership position in targeted protein degradation drug discovery research.</p> <p>&quot;Nurix is entering a new chapter as we evolve http://www.streetinsider.com/Press+Releases/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html Thu, 20 Aug 2026 07:00:00 -0400 A.15133668 A.26631359 A.50113906 NRIX O.13716952 O.19990958 O.19997584 O.48084002 http://www.streetinsider.com/Press+Releases/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html <p>BRISBANE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein degradation medicines for patients with cancer and inflammatory diseases, today announced that Wes Burwell has joined Nurix as its Chief Human Resources Officer (CHRO). Mr. Burwell will serve as a member of the company’s Executive Management Team and will lead Nurix&apos;s human resources organization as the company advances its late-stage clinical pipeline and prepares for commercialization while maintaining its leadership position in targeted protein degradation drug discovery research.</p> <p>&quot;Nurix is entering a new chapter as we evolve http://www.streetinsider.com/Press+Releases/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html Thu, 20 Aug 2026 07:00:00 -0400 A.15133668 A.26631359 A.50113906 NRIX O.13716952 O.19990958 O.19997584 O.48084002 http://www.streetinsider.com/Press+Releases/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html <p>BRISBANE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein degradation medicines for patients with cancer and inflammatory diseases, today announced that Wes Burwell has joined Nurix as its Chief Human Resources Officer (CHRO). Mr. Burwell will serve as a member of the company’s Executive Management Team and will lead Nurix&apos;s human resources organization as the company advances its late-stage clinical pipeline and prepares for commercialization while maintaining its leadership position in targeted protein degradation drug discovery research.</p> <p>&quot;Nurix is entering a new chapter as we evolve http://www.streetinsider.com/Press+Releases/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html Thu, 20 Aug 2026 07:00:00 -0400 A.15133668 A.26631359 A.50113906 NRIX O.13716952 O.19990958 O.19997584 O.48084002 http://www.streetinsider.com/Press+Releases/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html <p>BRISBANE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein degradation medicines for patients with cancer and inflammatory diseases, today announced that Wes Burwell has joined Nurix as its Chief Human Resources Officer (CHRO). Mr. Burwell will serve as a member of the company’s Executive Management Team and will lead Nurix&apos;s human resources organization as the company advances its late-stage clinical pipeline and prepares for commercialization while maintaining its leadership position in targeted protein degradation drug discovery research.</p> <p>&quot;Nurix is entering a new chapter as we evolve http://www.streetinsider.com/Press+Releases/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html Thu, 20 Aug 2026 07:00:00 -0400 A.15133668 A.26631359 A.50113906 NRIX O.13716952 O.19990958 O.19997584 O.48084002 http://www.streetinsider.com/Press+Releases/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html <p>BRISBANE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein degradation medicines for patients with cancer and inflammatory diseases, today announced that Wes Burwell has joined Nurix as its Chief Human Resources Officer (CHRO). Mr. Burwell will serve as a member of the company’s Executive Management Team and will lead Nurix&apos;s human resources organization as the company advances its late-stage clinical pipeline and prepares for commercialization while maintaining its leadership position in targeted protein degradation drug discovery research.</p> <p>&quot;Nurix is entering a new chapter as we evolve http://www.streetinsider.com/Press+Releases/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html Thu, 20 Aug 2026 07:00:00 -0400 A.15133668 A.26631359 A.50113906 NRIX O.13716952 O.19990958 O.19997584 O.48084002 http://www.streetinsider.com/Globe+Newswire/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html <p>BRISBANE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein degradation medicines for patients with cancer and inflammatory diseases, today announced that Wes Burwell has joined Nurix as its Chief Human Resources Officer (CHRO). Mr. Burwell will serve as a member of the company’s Executive Management Team and will lead Nurix&apos;s human resources organization as the company advances its late-stage clinical pipeline and prepares for commercialization while maintaining its leadership position in targeted protein degradation drug discovery research.</p> <p>&quot;Nurix is entering a new chapter as we evolve http://www.streetinsider.com/Globe+Newswire/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html Thu, 20 Aug 2026 07:00:00 -0400 A.15133668 A.26631359 A.50113906 NRIX O.13716952 O.19990958 O.19997584 O.48084002 http://www.streetinsider.com/Globe+Newswire/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html <p>BRISBANE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein degradation medicines for patients with cancer and inflammatory diseases, today announced that Wes Burwell has joined Nurix as its Chief Human Resources Officer (CHRO). Mr. Burwell will serve as a member of the company’s Executive Management Team and will lead Nurix&apos;s human resources organization as the company advances its late-stage clinical pipeline and prepares for commercialization while maintaining its leadership position in targeted protein degradation drug discovery research.</p> <p>&quot;Nurix is entering a new chapter as we evolve http://www.streetinsider.com/Globe+Newswire/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html Thu, 20 Aug 2026 07:00:00 -0400 A.15133668 A.26631359 A.50113906 NRIX O.13716952 O.19990958 O.19997584 O.48084002 http://www.streetinsider.com/Globe+Newswire/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html <p>BRISBANE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein degradation medicines for patients with cancer and inflammatory diseases, today announced that Wes Burwell has joined Nurix as its Chief Human Resources Officer (CHRO). Mr. Burwell will serve as a member of the company’s Executive Management Team and will lead Nurix&apos;s human resources organization as the company advances its late-stage clinical pipeline and prepares for commercialization while maintaining its leadership position in targeted protein degradation drug discovery research.</p> <p>&quot;Nurix is entering a new chapter as we evolve http://www.streetinsider.com/Globe+Newswire/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html Thu, 20 Aug 2026 07:00:00 -0400 A.15133668 A.26631359 A.50113906 NRIX O.13716952 O.19990958 O.19997584 O.48084002 http://www.streetinsider.com/Globe+Newswire/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html <p>BRISBANE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein degradation medicines for patients with cancer and inflammatory diseases, today announced that Wes Burwell has joined Nurix as its Chief Human Resources Officer (CHRO). Mr. Burwell will serve as a member of the company’s Executive Management Team and will lead Nurix&apos;s human resources organization as the company advances its late-stage clinical pipeline and prepares for commercialization while maintaining its leadership position in targeted protein degradation drug discovery research.</p> <p>&quot;Nurix is entering a new chapter as we evolve http://www.streetinsider.com/Globe+Newswire/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html Thu, 20 Aug 2026 07:00:00 -0400 A.15133668 A.26631359 A.50113906 NRIX O.13716952 O.19990958 O.19997584 O.48084002 http://www.streetinsider.com/Globe+Newswire/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html <p>BRISBANE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein degradation medicines for patients with cancer and inflammatory diseases, today announced that Wes Burwell has joined Nurix as its Chief Human Resources Officer (CHRO). Mr. Burwell will serve as a member of the company’s Executive Management Team and will lead Nurix&apos;s human resources organization as the company advances its late-stage clinical pipeline and prepares for commercialization while maintaining its leadership position in targeted protein degradation drug discovery research.</p> <p>&quot;Nurix is entering a new chapter as we evolve http://www.streetinsider.com/Globe+Newswire/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html Thu, 20 Aug 2026 07:00:00 -0400 A.15133668 A.26631359 A.50113906 NRIX O.13716952 O.19990958 O.19997584 O.48084002 http://www.streetinsider.com/Globe+Newswire/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html <p>BRISBANE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein degradation medicines for patients with cancer and inflammatory diseases, today announced that Wes Burwell has joined Nurix as its Chief Human Resources Officer (CHRO). Mr. Burwell will serve as a member of the company’s Executive Management Team and will lead Nurix&apos;s human resources organization as the company advances its late-stage clinical pipeline and prepares for commercialization while maintaining its leadership position in targeted protein degradation drug discovery research.</p> <p>&quot;Nurix is entering a new chapter as we evolve http://www.streetinsider.com/Globe+Newswire/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html Thu, 20 Aug 2026 07:00:00 -0400 A.15133668 A.26631359 A.50113906 NRIX O.13716952 O.19990958 O.19997584 O.48084002 http://www.streetinsider.com/Globe+Newswire/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html <p>BRISBANE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein degradation medicines for patients with cancer and inflammatory diseases, today announced that Wes Burwell has joined Nurix as its Chief Human Resources Officer (CHRO). Mr. Burwell will serve as a member of the company’s Executive Management Team and will lead Nurix&apos;s human resources organization as the company advances its late-stage clinical pipeline and prepares for commercialization while maintaining its leadership position in targeted protein degradation drug discovery research.</p> <p>&quot;Nurix is entering a new chapter as we evolve http://www.streetinsider.com/Globe+Newswire/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html Thu, 20 Aug 2026 07:00:00 -0400 A.15133668 A.26631359 A.50113906 NRIX O.13716952 O.19990958 O.19997584 O.48084002 http://www.streetinsider.com/Globe+Newswire/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html <p>BRISBANE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein degradation medicines for patients with cancer and inflammatory diseases, today announced that Wes Burwell has joined Nurix as its Chief Human Resources Officer (CHRO). Mr. Burwell will serve as a member of the company’s Executive Management Team and will lead Nurix&apos;s human resources organization as the company advances its late-stage clinical pipeline and prepares for commercialization while maintaining its leadership position in targeted protein degradation drug discovery research.</p> <p>&quot;Nurix is entering a new chapter as we evolve http://www.streetinsider.com/Globe+Newswire/Nurix+Therapeutics+Announces+Appointment+of+Wes+Burwell++as+Chief+Human+Resources+Officer/26952617.html Thu, 20 Aug 2026 07:00:00 -0400 A.15133668 A.26631359 A.50113906 NRIX O.13716952 O.19990958 O.19997584 O.48084002 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Redmile+Group%2C+LLC/26931144.html si-local-file:///var/storage/secattach/20260814/26931144.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Redmile+Group%2C+LLC/26931144.html Fri, 14 Aug 2026 16:26:00 -0400 NRIX O.48084002 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Redmile+Group%2C+LLC/26931144.html si-local-file:///var/storage/secattach/20260814/26931144.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Redmile+Group%2C+LLC/26931144.html Fri, 14 Aug 2026 16:26:00 -0400 NRIX O.48084002 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Vestal+Point+Capital%2C+LP/26930458.html si-local-file:///var/storage/secattach/20260814/26930458.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Vestal+Point+Capital%2C+LP/26930458.html Fri, 14 Aug 2026 16:13:00 -0400 NRIX O.48084002 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Vestal+Point+Capital%2C+LP/26930458.html si-local-file:///var/storage/secattach/20260814/26930458.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Vestal+Point+Capital%2C+LP/26930458.html Fri, 14 Aug 2026 16:13:00 -0400 NRIX O.48084002 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Rubric+Capital+Management+LP/26930323.html si-local-file:///var/storage/secattach/20260814/26930323.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Rubric+Capital+Management+LP/26930323.html Fri, 14 Aug 2026 16:10:00 -0400 NRIX O.48084002 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Rubric+Capital+Management+LP/26930323.html si-local-file:///var/storage/secattach/20260814/26930323.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Rubric+Capital+Management+LP/26930323.html Fri, 14 Aug 2026 16:10:00 -0400 NRIX O.48084002 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+PRICE+T+ROWE+ASSOCIATES+INC+MD/26926618.html si-local-file:///var/storage/secattach/20260814/26926618.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+PRICE+T+ROWE+ASSOCIATES+INC+MD/26926618.html Fri, 14 Aug 2026 10:39:00 -0400 NRIX O.48084002 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+PRICE+T+ROWE+ASSOCIATES+INC+MD/26926618.html si-local-file:///var/storage/secattach/20260814/26926618.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+PRICE+T+ROWE+ASSOCIATES+INC+MD/26926618.html Fri, 14 Aug 2026 10:39:00 -0400 NRIX O.48084002 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Deep+Track+Capital%2C+LP/26925250.html si-local-file:///var/storage/secattach/20260814/26925250.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Nurix+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Deep+Track+Capital%2C+LP/26925250.html Fri, 14 Aug 2026 08:37:00 -0400 NRIX O.48084002